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We report a case of a very fast and intriguing decrease in IgE concentrations after exclusion from the diet of any CM lysate in an
unusual clinical presentation of cow’s milk allergy in an infant. Analysis of IgE kinetics after allergen elimination suggests rapid
cessation of IgE biosynthesis and a short IgE half-life.
1.Introduction
Anunusualclinicalpresentationofcow’smilkallergy(CMA)
in an infant gave us the opportunity to observe a very fast
and intriguing decrease of IgE concentrations after allergen
withdrawal, raising new questions about IgE production and
metabolism in newborns and infants.
2.CaseReport
A 17-day-old neonate, born to atopic parents at full term,
was hospitalized in the children hospital of Tours (France)
for poor feeding and increasing diarrhoea for 4 days,
associated with a severe metabolic acidosis, after a symptom-
free interval of 2 weeks. The diarrhoea ceased soon after
admission. Erythema and a pustular rash of the face as well
as a “gloves and socks-” type skin rash were noted at 18 days
of age, leading to the ﬁnding of very high concentrations of
total IgE (1298kIU/L) and IgE speciﬁc to cow’s milk (CM)
(83kAU/L, Phadia) (Figure 1). First-stage formula milk had
been introduced on day 11 in addition to breastfeeding
according to the mother, although it is possible that this had
been given since birth. Although the clinical presentation
was very unusual and severe [1, 2], the diagnosis of CMA
was conﬁrmed by a rapid regression of all symptoms after
withdrawal of CM proteins. Seven days later, total IgE fell
to 121kIU/L and speciﬁc IgE to 1.44kAU/L, and total IgE
returned to within the normal range (10.5kIU/L) (Figure 1)
ﬁ v ed a y sl a t e r .
3. Discussion
The IgE detected in the newborn had been self-produced
since IgE did not cross the placenta and his mother had no
CM-speciﬁc IgE (not shown). This IgE immune response
thus probably reﬂected a rapid maturation of IgE+ B cells
into plasmablasts, as recently evidenced in mice [3]. No less
spectacular was the 100-fold decrease in IgE concentrations
12 days later (Figure 1), following exclusion of any CM lysate
from the diet. High levels of both speciﬁc and total IgE are
regularly observed in infant cow’s milk allergy [4]a n da r e
reminiscent of experimental models where their coexistence
reﬂects a genetic (atopic) background [5]. However, their
parallel evolution, and the fact that they both appeared to
be strictly antigen dependent, could also suggest that the IgE
measured in the “total” assay is mostly directed against CM.2 Journal of Allergy
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Figure 1: Evolution of total IgE (￿) and CM-speciﬁc IgE (). IgE
levels were measured on D19, D26, and D31. Predicted IgE kinetics
are indicated as a black bold line. Extrapolated IgE kinetics are
shownas grey lines (medianinbold, 5and 95% CIas normallines).
With only two values available, calculations were not performed for
speciﬁc IgE.
Pharmacokinetic modelling techniques were used to
describe the elimination kinetics of total IgE in this infant.
The kinetics model was ln(C(t)) = ln(Cn) − ke · t,w h e r e
C(t) is the IgE concentration over time (kIU/L), Cn is the
estimated IgE concentration just after CM withdrawal, ke
(day−1) is the ﬁrst-order elimination constant, and t (day)
is time. The ke parameter was estimated using log-linear
regression. The elimination half-life (T1/2) was calculated as
T1/2 = ln(2)/ke andwas1.7daysinthisinfant.Thecombined
kinetics of IgE and omalizumab, an anti-IgE humanized
monoclonal antibody, were previously described in adults
using PK-PD modelling [6]. The parameters describing the
interindividual distribution of IgE elimination kinetics in
this study were used to estimate the conﬁdence interval
containing 90% of T1/2 values (CI90T1/2), which was (1.5–
3.8) days. Although low, the T1/2 of IgE of our infant
was within this CI90T1/2 and thus has to be considered as
“normal.” However, to calculate this elimination kinetics,
it was postulated that IgE production ceased after CM
withdrawal, which is not necessarily the case. It is therefore
possible that the true IgE T1/2 of this patient may be shorter
than 1.7 days.
Nevertheless, our ﬁndings suggest that the IgE produc-
tion stopped rapidly—if not immediately—after allergen
elimination, suggesting that a very limited IgE plasmablast
life span combined with the very short IgE half-life. Whether
this hypothetical IgE plasmablast short life span is restricted
to IgE or whether it is due a more general immaturity of
lymphoid niches in the newborn, as suggested in murine
models[7],warrantsfurtherinvestigationsinacohortofCM
allergic newborns.
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